Literature DB >> 7348570

Hormone receptors and obesity in Japanese women with breast cancer.

K Kuno, A Fukami, M Hori, F Kasumi.   

Abstract

An association between hormone receptors in primary breast cancer and obesity determined prior to mastectomy was investigated in 128 Japanese women. The following criteria for obesity were used: (1) weight greater than or equal to 60 kg (132 lbs), (2) weight kg/height cm-105 greater than or equal to 1.3, (3) weight lbs/height in greater than or equal to 2.30, (4) body surface area greater than or equal to 1.56 m2. In view of the 4 criteria, tumor estrogen receptor (ER) values greater than or equal to 4 fmol/mg were observed in obese patients more often than in nonobese patients, though the difference was not statistically significant. The same tendency was observed in the postmenopausal subgroup, 62 patients, especially in the 36 patients more than 5 years beyond menopause. However, there was still no statistical difference between obese and nonobese patients because the number of subjects was small. The same tendency was observed in the case of progesterone receptor (PgR) (greater than or equal to 6 fmol/mg) as observed in the case of ER.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7348570     DOI: 10.1007/bf01805867

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

1.  A prospective study in general practice on breast-cancer risk in postmenopausal women.

Authors:  F de Waard; E A Baanders-van Halewijn
Journal:  Int J Cancer       Date:  1974-08-15       Impact factor: 7.396

2.  Estrogen receptor status and the disease-free interval in breast cancer.

Authors:  J C Allegra; M E Lippman
Journal:  Recent Results Cancer Res       Date:  1980

3.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

4.  Breast cancer in Japan and United States: epidemiology, hormone receptors, pathology, and survival.

Authors:  R H Yonemoto
Journal:  Arch Surg       Date:  1980-09

5.  Association between estrogen receptors and weight in women with breast cancer.

Authors:  A E Papatestas; D Panveliwalla; D Pertsemlidis; M Mulvihill; A H Aufses
Journal:  J Surg Oncol       Date:  1980       Impact factor: 3.454

6.  Relationship of oestrogen-receptor status to survival in breast cancer.

Authors:  H M Bishop; R W Blamey; C W Elston; J L Haybittle; R I Nicholson; K Griffiths
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

7.  Recurrence of breast cancer. Obesity, tumor size, and axillary lymph node metastases.

Authors:  A Sohrabi; J Sandoz; J S Spratt; H C Polk
Journal:  JAMA       Date:  1980-07-18       Impact factor: 56.272

8.  Prognostic value of estrogen receptors in primary breast cancer.

Authors:  R Hähnel; T Woodings; A B Vivian
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

9.  The association of body weight with recurrent cancer of the breast.

Authors:  W L Donegan; A J Hartz; A A Rimm
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

  9 in total
  4 in total

1.  Influence of estrogen receptor status on dietary risk factors for breast cancer.

Authors:  T G Hislop; L Kan; A J Coldman; P R Band; G Brauer
Journal:  CMAJ       Date:  1988-03-01       Impact factor: 8.262

2.  Estrogen receptor status of breast cancer in Ontario.

Authors:  G E McKeown-Eyssen; I Rogers-Melamed; E A Clarke
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

3.  Relationship between estrogen receptors and risk factors of breast cancer in Japanese pre- and postmenopausal patients.

Authors:  Y Nomura; H Tashiro; Y Hamada; T Shigematsu
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

4.  Association of vaginal smear cytology with menstrual status in breast cancer.

Authors:  R T Senie; S W Lobenthal; P P Rosen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.